These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7506027)

  • 1. Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.
    Im GJ; Tramontano E; Gonzalez CJ; Cheng YC
    Biochem Pharmacol; 1993 Dec; 46(12):2307-13. PubMed ID: 7506027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase.
    Meyer PR; Matsuura SE; Zonarich D; Chopra RR; Pendarvis E; Bazmi HZ; Mellors JW; Scott WA
    J Virol; 2003 Jun; 77(11):6127-37. PubMed ID: 12743270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.
    Reardon JE; Miller WH
    J Biol Chem; 1990 Nov; 265(33):20302-7. PubMed ID: 1700787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of HIV-1 reverse transcriptases encoding mutations at amino acid residues 161 and 208 involved in resistance to phosphonoformate.
    Tramontano E; Piras G; Mellors JW; Putzolu M; Bazmi HZ; La Colla P
    Biochem Pharmacol; 1998 Dec; 56(12):1583-9. PubMed ID: 9973178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.
    Jaju M; Beard WA; Wilson SH
    J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3'-Azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate: synthesis and HIV-1 reverse transcriptase inhibition.
    Freeman GA; Rideout JL; Miller WH; Reardon JE
    J Med Chem; 1992 Aug; 35(17):3192-6. PubMed ID: 1380561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates.
    Ueno T; Shirasaka T; Mitsuya H
    J Biol Chem; 1995 Oct; 270(40):23605-11. PubMed ID: 7559526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The M184V mutation reduces the selective excision of zidovudine 5'-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Apr; 76(7):3248-56. PubMed ID: 11884549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs.
    Maga G; Amacker M; Hübscher U; Gosselin G; Imbach JL; Mathé C; Faraj A; Sommadossi JP; Spadari S
    Nucleic Acids Res; 1999 Feb; 27(4):972-8. PubMed ID: 9927728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.
    Carroll SS; Geib J; Olsen DB; Stahlhut M; Shafer JA; Kuo LC
    Biochemistry; 1994 Mar; 33(8):2113-20. PubMed ID: 7509634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New thymidine triphosphate analogue inhibitors of human immunodeficiency virus-1 reverse transcriptase.
    Ma QF; Bathurst IC; Barr PJ; Kenyon GL
    J Med Chem; 1992 May; 35(11):1938-41. PubMed ID: 1375962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates.
    Mellors JW; Bazmi HZ; Schinazi RF; Roy BM; Hsiou Y; Arnold E; Weir J; Mayers DL
    Antimicrob Agents Chemother; 1995 May; 39(5):1087-92. PubMed ID: 7542860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective excision of chain-terminating nucleotides by HIV-1 reverse transcriptase with phosphonoformate as substrate.
    Cruchaga C; Ansó E; Rouzaut A; Martínez-Irujo JJ
    J Biol Chem; 2006 Sep; 281(38):27744-52. PubMed ID: 16829515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of the resistance of the human immunodeficiency virus to azidothymidine. I. Kinetic studies of the interaction between reverse transcriptase and a series of its mutant forms with substrates and azidothymidine-5'-trisphosphate].
    Pokholok DK; Gudima SO; Esipov DS; Dobrynin VN; Memelova LV; Rechinskiĭ VO; Kochetkov SN
    Biokhimiia; 1994 May; 59(5):739-47. PubMed ID: 7519060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis of the Glu-89 residue in human immunodeficiency virus type 1 (HIV-1) and HIV-2 reverse transcriptases: effects on nucleoside analog resistance.
    Song Q; Yang G; Goff SP; Prasad VR
    J Virol; 1992 Dec; 66(12):7568-71. PubMed ID: 1279207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active site.
    Klarmann GJ; Smith RA; Schinazi RF; North TW; Preston BD
    J Biol Chem; 2000 Jan; 275(1):359-66. PubMed ID: 10617626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside drug resistance in HIV-1 reverse transcriptase.
    Yadav PN; Yadav JS; Modak MJ
    Nat Struct Biol; 1995 Mar; 2(3):193-5. PubMed ID: 7539709
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
    Canard B; Sarfati SR; Richardson CC
    J Biol Chem; 1998 Jun; 273(23):14596-604. PubMed ID: 9603976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.